There is an Act in the Health Committee of the NYS Senate which would require hospitals to offer the hep C Test to Baby Boomers… Introduced by A. Zebrowski
Learn more
Last Updated on January 25, 2020 by HepFree NYC
Related Articles
-
From Hawaii to the Midwest: Strategies for Effective Hep B & C Response Event Highlights
This special event featured presentations on the Hep C Outbreak in Midwest and current Hepatitis programs in Hawaii.
-
Hepatitis C (HCV) Patient Summit (Early 2019)
The summit, NVHR’s first national patient gathering, will bring together 100 patients recently cured of or currently living with HCV who have not had experience engaging in other advocacy programs.
-
Hep C Screening: NYC Commissioner of Health Dear Colleague Letter (2013)
An estimated 145,000 New Yorkers are currently infected with HCV. Many New Yorkers with HCV remain undiagnosed, and one-third of those with a positive HCV antibody test have not had a confirmatory HCV RNA test. Many people diagnosed with HCV also do not receive appropriate counse...
-
Get on the phone! & tell Congress to attend hepatitis briefing on July 26th
On Thursday, July 26th, the Caring Ambassadors Program and NVHR are hosting a briefing on behalf of the Congressional Hepatitis Caucus on the hepatitis B and C epidemics for Members of Congress and their staff. This briefing is part of the Caucus’ ongoing efforts to highlight t...
-
New Two-Dose Hep B Vaccine Recommended by the Advisory Committee on Immunization Practices
The Advisory Committee on Immunization Practices’ (ACIP) recommend HEPLISAV-B™ for use among individuals age 18 years and older to prevent hepatitis B infection (HBV).
-
NY Organ Donor Network Volunteer Program
As a volunteer, you can make a difference today. Maybe you’re looking for opportunities to get out into the community? Perhaps you’re a strong speaker or storyteller? Maybe you're great with social media? We need YOU!
-
Medicare Guidelines | HCV screening for baby boomer & at risk beneficiaries
Overview: CMS has finalized its decision to reimburse for HCV screening in primary care settings, for individuals who are Medicare eligible and either “high risk” or born between 1945-1965. “High risk” is defined as persons with a current or past history of illi...
-
Mount Sinai Recanati/Miller Transplantation Institute HBV & HCV Clinical Trials
The Mount Sinai Recanati/Miller Transplantation Institute is currently participating in several Hepatitis B and Hepatitis C clinical trials.
